Firms
Theme

BUD

Anheuser-Busch INBEV SA/NV · NYSE

News

7 latest

Zacks Investment Research

Why Anheuser-Busch Inbev (BUD) is a Top Momentum Stock for the Long-Term

Anheuser-Busch InBev (BUD) is highlighted as a momentum stock worth watching, with a #3 (Hold) Zacks Rank and B-rated VGM and Momentum Style Scores. The stock has gained 6.3% over the past four weeks, with two analysts revising earnings estimates higher for fiscal 2026. The company's strong global brewing portfolio and market position support its growth prospects.

Zacks Investment Research

AB InBev's U.S. Beyond Beer Sales Surge in Q2: Can the Momentum Last?

Anheuser-Busch InBev (BUD) is experiencing significant momentum in its Beyond Beer category, with U.S. portfolio revenue growth in the mid-70% range during Q2 2026. The company's Cutwater brand achieved triple-digit revenue growth and became the No. 1 market share gainer in the U.S. spirits industry. BUD is leveraging its NUTRL portfolio and BeatBox acquisition to expand its ready-to-drink (RTD) spirits presence, supported by strong distribution networks and production capacity.

Mentions BUD

Zacks Investment Research

Boston Beer's Q3 Earnings on Horizon: What Surprise Awaits Investors?

Boston Beer (SAM) is expected to report Q3 2026 earnings growth of 1.2% to $4.30 per share despite a 2.6% revenue decline. Weakness in key brands like Twisted Tea and Truly, along with rising costs and tariff pressures, are headwinds.

Zacks Investment Research

Zacks Industry Outlook Anheuser-Busch InBev, Constellation Brands, Brown-Forman and Molson Coors

The beverage-alcohol industry is positioned for growth through innovation in ready-to-drink cocktails, low/no-alcohol offerings, and Gen Z engagement strategies. However, tariffs on imported materials and persistent softness in alcohol consumption pose margin pressures. Leading players like Anheuser-Busch InBev, Diageo, Constellation Brands, Brown-Forman, and Molson Coors are well-positioned to capitalize on premiumization and portfolio diversification trends.

Zacks Investment Research

5 Alcohol Stocks to Watch as Innovation Fuels Industry Growth

The Zacks Beverages – Alcohol industry is positioned in the top 43% of industries with a positive earnings outlook. Key growth drivers include ready-to-drink cocktails, low/no-alcohol beverages, and Gen Z engagement through experiential marketing.

Zacks Investment Research

SAM Pushes Innovation: Can New Cocktails & Coolers Gain Traction?

Boston Beer Company is innovating beyond traditional beer by launching Sinless Vodka Cocktails (30+ states) and LYTT Electric Coolers (5+ states). While early reception is positive, management expects meaningful contributions only by 2027. The company's peers—AB InBev, Diageo, and Brown-Forman—are also leveraging innovation in ready-to-drink formats to drive growth.

Zacks Investment Research

Constellation Brands' Pre-Q2 Earnings: Is It Poised to Beat Estimates?

Constellation Brands is expected to report 3.6% revenue growth but flat EPS in Q2 FY2027. While the beer business benefits from premiumization and Mexico capacity investments, the company faces headwinds from weak Wine & Spirits sales, uneven consumer demand, and inflation-driven cost pressures. The stock trades at an attractive valuation but carries a negative earnings surprise indicator.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $BUD · 0 threads

Sign in to post on $BUD

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev